HealthMore in Health→
Life Biosciences raises $80 million to advance a clinical test of anti-aging gene therapy
Key Takeaways
- Life Biosciences announced an $80 million financing round.
- The startup was co-founded by Harvard biologist David Sinclair.
- The funding is intended to support a clinical test of a one-time anti-aging gene therapy.
DE
DT Editorial Team··via endpoints.news